Repurposing of gallium‐based drugs for antibacterial therapy
- 14 February 2014
- journal article
- review article
- Published by Wiley in BioFactors
- Vol. 40 (3) , 303-312
Abstract
While the occurrence and spread of antibiotic resistance in bacterial pathogens is vanishing current anti‐infective therapies, the antibiotic discovery pipeline is drying up. In the last years, the repurposing of existing drugs for new clinical applications has become a major research area in drug discovery, also in the field of anti‐infectives. This review discusses the potential of repurposing previously approved gallium formulations in antibacterial chemotherapy. Gallium has no proven function in biological systems, but it can act as an iron‐mimetic in both prokaryotic and eukaryotic cells. The activity of gallium mostly relies on its ability to replace iron in redox enzymes, thus impairing their function and ultimately hampering cell growth. Cancer cells and bacteria are preferential gallium targets due to their active metabolism and fast growth. The wealth of knowledge on the pharmacological properties of gallium has opened the door to the repurposing of gallium‐based drugs for the treatment of infections sustained by antibiotic‐resistant bacterial pathogens, such asAcinetobacter baumanniiorPseudomonas aeruginosa,and for suppression ofMycobacterium tuberculosisgrowth. The promising antibacterial activity of gallium bothin vitroand in different animal models of infection raises the hope that gallium will confirm its efficacy in clinical trials, and will become a valuable therapeutic option to cure otherwise untreatable bacterial infections. © 2014 BioFactors, 40(3):303–312, 2014Keywords
Funding Information
- Italian Cystic Fibrosis Fundation (14/2010)
This publication has 88 references indexed in Scilit:
- Repurposing the antimycotic drug flucytosine for suppression ofPseudomonas aeruginosapathogenicityProceedings of the National Academy of Sciences, 2013
- In VitroandIn VivoAntimicrobial Activities of Gallium Nitrate against Multidrug-Resistant Acinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 2012
- In VitroandIn VivoBiological Activities of Iron Chelators and Gallium Nitrate against Acinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 2012
- The Antibacterial Activity of Ga3+Is Influenced by Ligand Complexation as Well as the Bacterial Carbon SourceAntimicrobial Agents and Chemotherapy, 2011
- In Vitro Activity of Gallium Maltolate against Staphylococci in Logarithmic, Stationary, and Biofilm Growth Phases: Comparison of Conventional and Calorimetric Susceptibility Testing MethodsAntimicrobial Agents and Chemotherapy, 2010
- Gallium Disrupts Iron Uptake by Intracellular and ExtracellularFrancisellaStrains and Exhibits Therapeutic Efficacy in a Murine Pulmonary Infection ModelAntimicrobial Agents and Chemotherapy, 2010
- The gallium complex KP46 exerts strong activity against primary explanted melanoma cells and induces apoptosis in melanoma cell linesMelanoma Research, 2009
- Iron availability and infectionBiochimica et Biophysica Acta (BBA) - General Subjects, 2009
- Gallium Maltolate Treatment EradicatesPseudomonas aeruginosaInfection in Thermally Injured MiceAntimicrobial Agents and Chemotherapy, 2009
- The potential of desferrioxamine-gallium as an anti- Pseudomonas therapeutic agentProceedings of the National Academy of Sciences, 2008